Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-1.92%||6.14||0.7%||$429.21m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.59%||552.11||2.7%||$426.22m|
|GILD||Gilead Sciences, Inc.||1.52%||66.90||1.0%||$414.02m|
|XLRN||Acceleron Pharma, Inc.||0.43%||173.74||5.3%||$364.00m|
|VRTX||Vertex Pharmaceuticals, Inc.||2.55%||185.41||1.9%||$264.85m|
|XENE||Xenon Pharmaceuticals, Inc.||-2.96%||29.81||0.4%||$166.66m|
|DNA||Ginkgo Bioworks Holdings, Inc.||20.21%||14.81||0.0%||$162.54m|
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.